JOY AHANONU: Open Payments
NPI 1588837090 · CATONSVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,186 in 45 payments from 13 companies in 2025. Trend: 2023 $373 · 2024 $745 · 2025 $1,186
Food & beverage: $1,167Education: $19
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $264 |
| AstraZeneca Pharmaceuticals LP | 7 | $179 |
| Amgen Inc. | 3 | $159 |
| ABBVIE INC. | 4 | $105 |
| Astellas Pharma US Inc | 4 | $104 |
| Lilly USA, LLC | 4 | $76 |
| Merck Sharp & Dohme LLC | 3 | $73 |
| PFIZER INC. | 4 | $67 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $44 |
| Abbott Laboratories | 2 | $41 |
Products named: Ozempic, REPATHA, Veozah, BREZTRI, QULIPTA, MOUNJARO, FARXIGA, Kerendia.
Industry payments across MD — which companies pay providers there.
